FDA Inspection 633558 — Haw Par Healthcare Limited
The FDA completed an inspection of Haw Par Healthcare Limited on Oct 29, 2009 in Singapore. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 29, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Postmarket Surv. and Epidemiology
- Location
- Singapore (Singapore)